338 related articles for article (PubMed ID: 22665070)
21. Body mass index is an independent predictor of long-term outcomes in patients hospitalized with heart failure in Japan.
Hamaguchi S; Tsuchihashi-Makaya M; Kinugawa S; Goto D; Yokota T; Goto K; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
Circ J; 2010 Nov; 74(12):2605-11. PubMed ID: 21060207
[TBL] [Abstract][Full Text] [Related]
22. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS
JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139
[TBL] [Abstract][Full Text] [Related]
23. Mode of death in patients with heart failure and reduced vs. preserved ejection fraction: report from the registry of hospitalized heart failure patients.
Hamaguchi S; Kinugawa S; Sobirin MA; Goto D; Tsuchihashi-Makaya M; Yamada S; Yokoshiki H; Tsutsui H;
Circ J; 2012; 76(7):1662-9. PubMed ID: 22481105
[TBL] [Abstract][Full Text] [Related]
24. Comparison of one-year outcome (death and rehospitalization) in hospitalized heart failure patients with left ventricular ejection fraction >50% versus those with ejection fraction <50%.
Ezekowitz JA; Lee DS; Tu JV; Newman AM; McAlister FA
Am J Cardiol; 2008 Jul; 102(1):79-83. PubMed ID: 18572040
[TBL] [Abstract][Full Text] [Related]
25. Spironolactone use is associated with improved outcomes in heart failure with mid-range ejection fraction.
Enzan N; Matsushima S; Ide T; Kaku H; Higo T; Tsuchihashi-Makaya M; Tsutsui H
ESC Heart Fail; 2020 Feb; 7(1):339-347. PubMed ID: 31951680
[TBL] [Abstract][Full Text] [Related]
26. Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction.
Ter Maaten JM; Martens P; Damman K; Dickstein K; Ponikowski P; Lang CC; Ng LL; Anker SD; Samani NJ; Filippatos G; Cleland JG; Zannad F; Hillege HL; van Veldhuisen DJ; Metra M; Voors AA; Mullens W
Clin Res Cardiol; 2020 Aug; 109(8):1048-1059. PubMed ID: 32002631
[TBL] [Abstract][Full Text] [Related]
27. Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis.
Täger T; Fröhlich H; Grundtvig M; Seiz M; Schellberg D; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L
Int J Cardiol; 2019 Aug; 289():83-90. PubMed ID: 30827731
[TBL] [Abstract][Full Text] [Related]
28. Loop Diuretic Prescription and Long-Term Outcomes in Heart Failure: Association Modification by Congestion.
Faselis C; Lam PH; Patel S; Arundel C; Filippatos G; Deedwania P; Zile MR; Wopperer S; Nguyen T; Allman RM; Fonarow GC; Ahmed A
Am J Med; 2021 Jun; 134(6):797-804. PubMed ID: 33359271
[TBL] [Abstract][Full Text] [Related]
29. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L;
Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337
[TBL] [Abstract][Full Text] [Related]
30. Use of short-acting vs. long-acting loop diuretics after heart failure hospitalization.
Imaeda S; Shiraishi Y; Kohsaka S; Niimi N; Goda A; Nagatomo Y; Takei M; Saji M; Nakano S; Kohno T; Fukuda K; Yoshikawa T
ESC Heart Fail; 2022 Oct; 9(5):2967-2977. PubMed ID: 35730147
[TBL] [Abstract][Full Text] [Related]
31. Diuretic therapy as prognostic enrichment factor for clinical trials in patients with heart failure with reduced ejection fraction.
Coiro S; Girerd N; McMurray JJV; Pitt B; Swedberg K; van Veldhuisen DJ; Lamiral Z; Rossignol P; Zannad F
Clin Res Cardiol; 2021 Aug; 110(8):1308-1320. PubMed ID: 33956209
[TBL] [Abstract][Full Text] [Related]
32. Superiority of long-acting to short-acting loop diuretics in the treatment of congestive heart failure.
Masuyama T; Tsujino T; Origasa H; Yamamoto K; Akasaka T; Hirano Y; Ohte N; Daimon T; Nakatani S; Ito H
Circ J; 2012; 76(4):833-42. PubMed ID: 22451450
[TBL] [Abstract][Full Text] [Related]
33. Association between changes in loop diuretic dose and outcomes in acute heart failure.
Seko Y; Kato T; Morimoto T; Yaku H; Inuzuka Y; Tamaki Y; Ozasa N; Shiba M; Yamamoto E; Yoshikawa Y; Yamashita Y; Kitai T; Taniguchi R; Iguchi M; Nagao K; Kawai T; Komasa A; Nishikawa R; Kawase Y; Morinaga T; Toyofuku M; Furukawa Y; Ando K; Kadota K; Sato Y; Kuwahara K; Kimura T;
ESC Heart Fail; 2023 Jun; 10(3):1757-1770. PubMed ID: 36858382
[TBL] [Abstract][Full Text] [Related]
34. Impact of short-acting loop diuretic doses and cardiac sympathetic nerve abnormalities on outcomes of patients with reduced left ventricular function.
Onitsuka H; Koyama S; Ideguchi T; Ishikawa T; Kitamura K; Nagamachi S
Medicine (Baltimore); 2019 Feb; 98(8):e14657. PubMed ID: 30813209
[TBL] [Abstract][Full Text] [Related]
35. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
Kontogeorgos S; Thunström E; Johansson MC; Fu M
Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
[TBL] [Abstract][Full Text] [Related]
36. Loop diuretic down-titration at discharge in patients hospitalized for acute heart failure.
Croset F; Llàcer P; Núñez J; Campos J; García M; Pérez A; Fernández C; Fabregate M; López G; Tello S; Fernández JM; Ruiz R; Manzano L
ESC Heart Fail; 2024 Jun; 11(3):1739-1747. PubMed ID: 38454739
[TBL] [Abstract][Full Text] [Related]
37. Outcomes in patients treated with loop diuretics without a diagnosis of heart failure: a retrospective cohort study.
Cuthbert JJ; Soyiri I; Lomax SJ; Turgoose J; Fuat A; Cohen J; Clark AL
Heart; 2024 May; 110(12):854-862. PubMed ID: 38631899
[TBL] [Abstract][Full Text] [Related]
38. Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
Greene SJ; Velazquez EJ; Anstrom KJ; Clare RM; DeWald TA; Psotka MA; Ambrosy AP; Stevens GR; Rommel JJ; Alexy T; Ketema F; Kim DY; Desvigne-Nickens P; Pitt B; Eisenstein EL; Mentz RJ;
Circulation; 2023 Jul; 148(2):124-134. PubMed ID: 37212600
[TBL] [Abstract][Full Text] [Related]
39. Reduced Diuretic Dose in Patients Treated With Eplerenone: Data From the EPHESUS Trial.
Ferreira JP; Eschalier R; Duarte K; Damman K; Gustafsson F; Schou M; Girerd N; Fay R; Tala S; Pitt B; Zannad F; Rossignol P
Circ Heart Fail; 2020 May; 13(5):e006597. PubMed ID: 32354280
[TBL] [Abstract][Full Text] [Related]
40. Comparative Analysis of Long-Term Outcomes of Torasemide and Furosemide in Heart Failure Patients in Heart Failure Registries of the European Society of Cardiology.
Ozierański K; Balsam P; Kapłon-Cieślicka A; Tymińska A; Kowalik R; Grabowski M; Peller M; Wancerz A; Marchel M; Crespo-Leiro MG; Maggioni AP; Drożdż J; Filipiak KJ; Opolski G
Cardiovasc Drugs Ther; 2019 Feb; 33(1):77-86. PubMed ID: 30649675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
